← Leaderboards
Vineet N Kewalramani
Basic Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Basic Sciences
Same institution · by research overlap
Others in their field
Top investigators on “Hiv-1”
- Barton F Haynes · Duke University$476,288,740
- Lawrence Corey · Fred Hutchinson Cancer Center$445,419,385
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$294,186,693
- Constance Ann Benson · University Of California, San Diego$272,046,180
- Peter B. Gilbert · Fred Hutchinson Cancer Center$173,010,936
- Dan H. Barouch · Fred Hutchinson Cancer Center$166,542,502
Research focus
Hiv-1CellsInfectionVirusIntegration Host FactorsMutationNuclearAntiviral AgentsComplexCytoplasmProteinsCell NucleusNuclear PoreTraffickingPathway InteractionsRoutePore ProteinsKaryopherinsGeneticReportingSite VisitAntiviral TherapyC-TerminalReceptor
Grant awards (61)
The role of CPSF6 in HIV-1 infection$358,723
ZIA · FY2025 · CA · contact PI
The role of POM121 in HIV-1 infection$179,362
ZIA · FY2025 · CA · contact PI
HIV-1 passage through the nuclear pore complex$179,362
ZIA · FY2025 · CA · contact PI
The role of CPSF6 in HIV-1 infection$680,049
ZIA · FY2024 · CA · contact PI
The role of POM121 in HIV-1 infection$340,025
ZIA · FY2024 · CA · contact PI
HIV-1 passage through the nuclear pore complex$340,025
ZIA · FY2024 · CA · contact PI
The role of CPSF6 in HIV-1 infection$591,692
ZIA · FY2023 · CA · contact PI
The role of POM121 in HIV-1 infection$295,847
ZIA · FY2023 · CA · contact PI
HIV-1 passage through the nuclear pore complex$295,847
ZIA · FY2023 · CA · contact PI
The role of CPSF6 in HIV-1 infection$791,581
ZIA · FY2022 · CA · contact PI
SARS-CoV-2 and HIV-1 Interactions with C-Type Lectins$395,790
ZIA · FY2022 · CA · contact PI
HIV-1 passage through the nuclear pore complex$395,790
ZIA · FY2022 · CA · contact PI
The role of CPSF6 in HIV-1 infection$713,973
ZIA · FY2021 · CA · contact PI
SARS-CoV-2 and HIV-1 Interactions with C-Type Lectins$356,986
ZIA · FY2021 · CA · contact PI
HIV-1 passage through the nuclear pore complex$356,986
ZIA · FY2021 · CA · contact PI
The role of CPSF6 in HIV-1 infection$836,229
ZIA · FY2020 · CA · contact PI
HIV-1 passage through the nuclear pore complex$418,115
ZIA · FY2020 · CA · contact PI
HIV-1 evasion of cytosolic factors$139,371
ZIA · FY2020 · CA · contact PI
The role of CPSF6 in HIV-1 infection$804,926
ZIA · FY2019 · CA · contact PI
HIV-1 passage through the nuclear pore complex$402,463
ZIA · FY2019 · CA · contact PI
HIV-1 evasion of cytosolic factors$134,154
ZIA · FY2019 · CA · contact PI
The role of CPSF6 in HIV-1 infection$746,759
ZIA · FY2018 · CA · contact PI
HIV-1 passage through the nuclear pore complex$373,379
ZIA · FY2018 · CA · contact PI
HIV-1 evasion of cytosolic factors$124,460
ZIA · FY2018 · CA · contact PI
The role of CPSF6 in HIV-1 infection$844,020
ZIA · FY2017 · CA · contact PI
HIV-1 passage through the nuclear pore complex$422,010
ZIA · FY2017 · CA · contact PI
HIV-1 evasion of cytosolic factors$140,670
ZIA · FY2017 · CA · contact PI
The role of CPSF6 in HIV-1 infection$774,457
ZIA · FY2016 · CA · contact PI
HIV-1 passage through the nuclear pore complex$387,228
ZIA · FY2016 · CA · contact PI
HIV-1 evasion of cytosolic nucleic acid sensors$129,076
ZIA · FY2016 · CA · contact PI
Cytoplasmic-Nuclear Trafficking of HIV-1$955,029
ZIA · FY2015 · CA · contact PI
The Role of RISC Proteins in HIV-1 Replication$119,378
ZIA · FY2015 · CA · contact PI
Animal Models for HIV-1 Replication and Pathogenesis$119,378
ZIA · FY2015 · CA · contact PI
Cytoplasmic-Nuclear Trafficking of HIV-1$1,198,956
ZIA · FY2014 · CA · contact PI
The Role of RISC Proteins in HIV-1 Replication$149,869
ZIA · FY2014 · CA · contact PI
Animal Models for HIV-1 Replication and Pathogenesis$149,869
ZIA · FY2014 · CA · contact PI
Cytoplasmic-Nuclear Trafficking of HIV-1$1,037,098
ZIA · FY2013 · CA · contact PI
The Role of RISC Proteins in HIV-1 Replication$129,637
ZIA · FY2013 · CA · contact PI
Animal Models for HIV-1 Replication and Pathogenesis$129,637
ZIA · FY2013 · CA · contact PI
Cytoplasmic-Nuclear Trafficking of HIV-1$815,094
ZIA · FY2012 · CA · contact PI
The Role of RISC Proteins in HIV-1 Replication$271,698
ZIA · FY2012 · CA · contact PI
Animal Models for HIV-1 Replication and Pathogenesis$271,698
ZIA · FY2012 · CA · contact PI
Cytoplasmic-Nuclear Trafficking of HIV-1$618,950
ZIA · FY2011 · CA · contact PI
Animal Models for HIV-1 Replication and Pathogenesis$337,609
ZIA · FY2011 · CA · contact PI
Mechanism of DC-SIGN-Mediated Transmission of HIV$168,805
ZIA · FY2011 · CA · contact PI
Cytoplasmic-Nuclear Trafficking of HIV-1$640,206
ZIA · FY2010 · CA · contact PI
Animal Models for HIV-1 Replication and Pathogenesis$349,204
ZIA · FY2010 · CA · contact PI
Mechanism of DC-SIGN-Mediated Transmission of HIV$174,601
ZIA · FY2010 · CA · contact PI
The Postentry Pathway of HIV-1$572,141
ZIA · FY2009 · CA · contact PI
New Animal Models to Study HIV-1 Pathogenesis, Therapy, and Reservoirs$312,076
ZIA · FY2009 · CA · contact PI
Mechanism of DC-SIGN-Mediated Transmission of HIV$156,039
ZIA · FY2009 · CA · contact PI
The Postentry Pathway of HIV-1$649,948
Z01 · FY2008 · CA · contact PI
New Animal Models to Study HIV-1 Pathogenesis, Therapy, and Reservoirs$354,517
Z01 · FY2008 · CA · contact PI
The Postentry Pathway of HIV-1$730,593
Z01 · FY2007 · CA · contact PI
New Animal Models to Study HIV-1 Pathogenesis, Therapy, and Reservoirs$398,506
Z01 · FY2007 · CA · contact PI
A Macaque Model to Study HIV-1 RT Antiviral Therapy and$0
Z01 · FY2006 · BC · contact PI
Postentry Factors That Positively or Negatively Impact H$0
Z01 · FY2006 · BC · contact PI
Development of a Macaque Model to Evaluate HIV-1 Nonnucl$0
Z01 · FY2005 · BC
Postentry Factors That Positively or Negatively Impact H$0
Z01 · FY2005 · BC
Macaque Model to Evaluate HIV-1 Nonnucleoside RT$0
Z01 · FY2004 · BC
Development of a Macaque Model to Evaluate HIV-1 NNRTI$0
Z01 · FY2003 · BC